CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
2 hedge funds and large institutions have $226K invested in Global X China Biotech Innovation ETF in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$225K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1K |
Top Sellers
| 1 |
Jane Street
New York
|
-$180K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.5K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $225K | +$225K | +24,943 | New |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1K | +100 | New |
|
|
3
Jane Street
New York
| – | -$180K | -19,093 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$14.5K | -1,538 | Closed |
|